Details of events occurred from 3 and 6 months of follow-up
| Sex . | Age (y) . | Type of event . | Event time (d) . | Event details . |
|---|---|---|---|---|
| M | 69 | SVT recurrence | 96 | Symptomatic portal vein thrombosis in infiltrative hepatocellular carcinoma during treatment with rivaroxaban 20 mg once daily; switched to LMWH |
| F | 76 | Death (non–SVT related)* | 98 | Death for clinical deterioration in esophageal cancer progression |
| F | 70 | CRNMB | 102 | Profuse epistaxis during treatment with rivaroxaban 20 mg once daily; finding of varices of the nasal septum treated with nasal packing; anticoagulation was temporarily stopped and then restarted on reduced dose of rivaroxaban |
| F | 44 | CRNMB | 117 | Menometrorrhagia with mild anemia during treatment with rivaroxaban 20 mg once daily; treated with tranexamic acid; patient was then switched to VKA |
| F | 73 | Death (non–SVT related) | 136 | Death for clinical deterioration in pancreatic cancer progression |
| F | 55 | MB† | 187 | Rectorrhagia in adenocarcinoma of the rectum with intestinal stoma; during treatment with rivaroxaban 20 mg once daily, severe anemia (Hb drop ≥2 g/dL) required hospitalization and red blood cells transfusion; anticoagulation was temporarily stopped; patient was then switched to LMWH |
| Sex . | Age (y) . | Type of event . | Event time (d) . | Event details . |
|---|---|---|---|---|
| M | 69 | SVT recurrence | 96 | Symptomatic portal vein thrombosis in infiltrative hepatocellular carcinoma during treatment with rivaroxaban 20 mg once daily; switched to LMWH |
| F | 76 | Death (non–SVT related)* | 98 | Death for clinical deterioration in esophageal cancer progression |
| F | 70 | CRNMB | 102 | Profuse epistaxis during treatment with rivaroxaban 20 mg once daily; finding of varices of the nasal septum treated with nasal packing; anticoagulation was temporarily stopped and then restarted on reduced dose of rivaroxaban |
| F | 44 | CRNMB | 117 | Menometrorrhagia with mild anemia during treatment with rivaroxaban 20 mg once daily; treated with tranexamic acid; patient was then switched to VKA |
| F | 73 | Death (non–SVT related) | 136 | Death for clinical deterioration in pancreatic cancer progression |
| F | 55 | MB† | 187 | Rectorrhagia in adenocarcinoma of the rectum with intestinal stoma; during treatment with rivaroxaban 20 mg once daily, severe anemia (Hb drop ≥2 g/dL) required hospitalization and red blood cells transfusion; anticoagulation was temporarily stopped; patient was then switched to LMWH |